ck0001517767-20250930

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act File Number 811-22554

Carlyle Credit Income Fund

(Exact Name of Registrant as Specified In Its Charter)

One Vanderbilt Avenue, Suite 3400

New York, New York 10017

(Address of principal executive offices) (Zip Code)

Joshua Lefkowitz, Esq.

Chief Legal Officer, Carlyle Credit Income Fund

One Vanderbilt Avenue, Suite 3400

New York, New York 10017

(Name and address of agent for service)

Registrant’s telephone number, including area code: (212) 813-4900

Date of fiscal year end: September 30

Date of reporting period: September 30, 2025

Item 1. Reports to Stockholders

The annual report to stockholders for the year ended September 30, 2025 is filed herewith pursuant to Rule 30e -1 under the Investment Company Act of 1940.

CARLYLE CREDIT INCOME FUND

ANNUAL REPORT

SEPTEMBER 30, 2025

Table of Contents


Section			Page
Year End 2025 Shareholder Letter			1
Important Information about this Report and Carlyle Credit Income Fund			3
Performance Data			7
Summary of Certain Unaudited Portfolio Characteristics			8
Fees and Expenses			10
Statement of Assets and Liabilities			12
Schedule of Investments			13
Statement of Operations			16
Statements of Changes in Net Assets			17
Statement of Cash Flows			18
Financial Highlights			19
Notes to Financial Statements			21
Results of Shareholder Meeting			41
Report of Independent Registered Public Accounting Firm			42
Price Range of Common Shares			43
Dividend Reinvestment Plan			44
Management of the Fund			45
Approval of Investment Advisory Agreement			47
Portfolio Proxy Voting Policies and Proxy Voting Record			50
Additional Information			51

Letter to Shareholders and Management’s Discussion of Fund Performance

FUND REVIEW & DISCUSSION OF PERFORMANCE

On November 18, 2025, Carlyle Credit Income Fund (“we,” “us,” “our,” “CCIF” or the “Fund”) (NYSE: CCIF) announced via press release the financial results for the fourth quarter ending September 30, 2025. Over the past year, the Fund has successfully implemented the following:

•The fund currently holds a diversified portfolio consisting of 54 unique collateralized loan obligation (“CLO”) investments managed by 27 different collateral managers with exposure to 2,032 separate loans.

•The weighted average GAAP yield of the portfolio is 14.44% as of September 30, 2025.

•The fund completed 30 accretive CLO refinancings and resets in the underlying portfolio to either reduce the weighted average cost of debt in the CLO or to extend the reinvestment period.

•We maintained a 24.14% annualized dividend based on the share price as of November 12, 2025.

•The Fund continues to incorporate an at-the-market (“ATM”) offering program to issue common shares above net asset value (“NAV”) when the stock price is above NAV. We continue to believe the implementation of the ATM offering program is an efficient and accretive way to grow the Fund. ATM issuance for the year totaled $32.3 million of net proceeds.

•We continue to efficiently leverage the fund with long-term and flexible-term preferred stock and convertible preferred stock with limited covenants.

As of September 30, 2025, the NAV of the Fund is $6.13 per share.

The Fund continues to hold one legacy real estate asset in the portfolio that was inherited from the prior advisor of the Fund. The fair market value of the loan is $2.2 million and the third party we engaged to sell the position continues to work through the process in order to maximize proceeds.

We believe Carlyle’s 15 years of CLO investment experience and its team of over 30+ credit investment professionals across the U.S. and Europe provide differentiated insights into the CLO market. Carlyle remains one of the largest CLO managers globally with

over $49 billion in AUM and $3.1 billion in third party managed CLO investments.1

MARKET REVIEW

Leveraged loans posted positive returns through Q3 2025 amid shifting expectations for the Federal Reserve’s (“Fed’s”) rate cuts. The LSTA U.S. Leveraged Loan Index (“LSTA Index”) returned 1.7% for the Q3 2025, compared to 2.4% for high yield bonds and 7.9% for the S&P 500. The year-to-date return for the LSTA Index was 4.6%.2,3,4 The Index price ended the quarter at $97.06, with nearly half of the loans trading above par.2 The Fed implemented its first rate cut of the cycle in September amid moderating inflation and relatively stable economic conditions.

Institutional loan issuance totaled $384.0 billion in Q3 2025, compared to $222.0 billion in Q3 2024.5 Refinancing and repricing activity accounted for the majority of volume at $66.5 billion and $219.2 billion, respectively, as borrowers continued to focus on extending maturities and reducing borrowing costs.5 New money issuance remained limited, with LBO and M&A related volume relatively unchanged from the third quarter of the prior year. Loan secondary prices held steady through the quarter amid consistent investor demand and limited net supply.5 Additionally, issuance activity strengthened toward the end of the quarter driven by steady demand and favorable technical conditions. We expect activity will continue to increase, supported by declining base rates driving lower funding costs, normalization of tariff and regulatory policies, and resilient expectations for economic growth.

The CLO market remained active through Q3 2025, building on the steady momentum seen earlier in the year. New issuance totaled $52.2 billion in the quarter, up from $48.5 billion in Q2 2025, as managers benefited from improved market conditions and modest tightening in liability spreads.5 CLOs continued to represent the dominant source of demand for leveraged loans, helping to absorb steady primary issuance and support secondary market liquidity. Liability spreads compressed across the capital stack, with AAAs tightening by roughly 10 bps and BBs by around 40 bps, approaching the post-financial crisis tights we saw earlier in 2025.6 This is creating an attractive environment for new issue and refinancing activity.

CLO refinancing and reset activity also remained robust, with $37.7 billion of refinancings and $66.1 billion of resets pricing during the quarter as managers extended

1 Carlyle Internal Sources as of September 30, 2025.

2 Leveraged Commentary & Data (“LCD”) as of September 30, 2025.

3 Bloomberg as of September 30, 2025.

4 Standard and Poor’s Dow Jones Indices as of September 30, 2025.

5 LevFin Insights as of September 30, 2025.

6 Wells Fargo Research as of September 30, 2025.

reinvestment periods and lowered financing costs.7 Market tone improved late in the quarter following the Federal Reserve’s rate cut, providing a constructive backdrop for deal execution.

Credit fundamentals across CLO portfolios remained stable. As of Q2 2025, using Carlyle’s U.S. loan portfolio of 600+ borrowers as a proxy, more than 67% of borrowers generated positive free cash flow, and borrower revenue and EBITDA growth of 5.1% and 4.6% year-over-year, respectively.8 The average Interest Coverage Ratio (“ICR”) was approximately 3.6x, reflecting a continued focus on managing interest expense and producing steady underlying cash flows.8 These metrics offer important insight into the health of the underlying collateral and continue to guide our bottom-up CLO investment process.

As of September 30, 2025, the J.P. Morgan Leveraged Loan Index Default Rate, including distressed exchanges (“DEs”), totals 3.49%, a decline of 1.00% from the recent peak default rate of 4.49% in December 2024.9 Carlyle continues to leverage the insights of its dedicated Special Credits Group and 30+ credit analysts when evaluating loan borrowers in third-party managed CLO portfolios. This is evidenced by a CCIF portfolio default rate of 1.09%, inclusive of DEs, which is approximately one-third of the market’s rate.1,9

While lower liability costs and extended reinvestment periods have supported CLO structures, tighter loan spreads continued to weigh on equity cash-on-cash distributions to CLO equity and fair market value of CLO equity positions. Repricing activity has been driven by the supply / demand imbalance in the loan market as net loan issuance has been limited over the past 3 year while we continue to see record CLO issuance. As a result, quarterly payments for CLO equity declined modestly during the quarter. However, locking in low-cost debt with extended reinvestment periods, positions CLO equity for improved cash flow potential in the event loan spreads widen due to volatility or a return of net loan supply.

STRATEGY & OUTLOOK

We remain confident in the resilience of our portfolio, which is diversified across high-quality managers and structured to withstand evolving market conditions.

We believe that, despite tighter spreads and moderating equity distributions, resilient fundamentals and consistent demand will continue to support CLO performance. Loan spreads have historically moved in multi-year cycles, and current levels are comparable to those observed in 2018, a period that was followed by meaningful spread widening.2

CLO equity is well positioned to benefit from similar dynamics ahead, supported by transactions with

historically low funding costs. Future results are likely to depend on manager’s reinvestment discipline and their effectiveness in actively managing the portfolio and avoiding losses.

We continue to monitor the effects of shifting rate policy and have positioned CCIF’s portfolio defensively, with a focus on experienced managers and portfolios demonstrating strong par build and credit discipline. This approach has resulted in a weighted average junior overcollateralization cushion of 4.59%.1

We continue to deploy capital selectively, focusing on opportunities that offer compelling relative value across both new and seasoned transactions. Carlyle’s market-leading platform provides differentiated access to managers and deal flow, enabling us to identify attractive entry points and maintain a disciplined investment pace.

For CCIF, we remain focused on CLO equity positions with clean underlying loan portfolios. We continue to leverage Carlyle’s 14-step CLO investment process and the credit expertise of the broader Carlyle Liquid Credit platform.

7 Citi Global Research as of September 30, 2025.

8 Carlyle Internal Sources as of June 30, 2025.

9 J.P. Morgan as of September 30, 2025.

IMPORTANT INFORMATION ABOUT THIS REPORT AND CARLYLE CREDIT INCOME FUND

Investment Objectives and Strategies

The Fund is a non-diversified, closed-end management investment company that has registered as an investment company under the 1940 Act. We have elected to be treated, and intend to qualify annually, as a regulated investment company, or “RIC,” under Subchapter M of the Internal Revenue Code of 1986, as amended, or the “Code.”

The Fund’s primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. We seek to achieve our investment objectives by investing primarily in equity and junior debt tranches of collateralized loan obligations, or “CLOs,” that are collateralized by a portfolio consisting primarily of below investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. We may also invest in other related securities and instruments or other securities and instruments that the Adviser believes are consistent with our investment objectives, including senior debt tranches of CLOs, loan accumulation facilities (“LAFs”) and securities issued by other securitization vehicles, such as collateralized bond obligations, or “CBOs.” LAFs are short- to medium-term facilities often provided by the bank that will serve as the placement agent or arranger on a CLO transaction. LAFs typically incur leverage between four and six times equity value prior to a CLO’s pricing. The CLO securities in which we primarily seek to invest are unrated or rated below investment grade and are considered speculative with respect to timely payment of interest and repayment of principal. Unrated and below investment grade securities are also sometimes referred to as “junk” securities. In addition, the CLO equity and junior debt securities in which we invest are highly leveraged (with CLO equity securities typically being leveraged ten times), which magnifies our risk of loss on such investments.

“Names Rule” Policy

In accordance with the requirements of the 1940 Act, we have adopted a policy to invest at least 80% of our assets in the particular type of investments suggested by our name. Accordingly, under normal circumstances, we invest at least 80% of the aggregate of its net assets and borrowings for investment purposes in credit and credit-related instruments. For purposes of this policy, the Fund considers credit and credit-related instruments to include, without limitation: (i) equity and debt tranches of CLOs, LAFs and securities issued by other securitization vehicles, such as CBOs; (ii) secured and unsecured floating rate and fixed rate loans; (iii) investments in corporate debt obligations, including bonds, notes, debentures, commercial paper and other obligations of corporations to pay interest and repay principal; (iv) debt issued by governments, their agencies, instrumentalities, and central banks; (v) commercial paper and short-term notes; (vi) convertible debt securities; (vii) certificates of deposit, bankers’ acceptances and time deposits; and (viii) other credit-related instruments. The Fund’s investments in derivatives, other investment companies, and other instruments designed to obtain indirect exposure to credit and credit-related instruments will be counted towards its 80% investment policy to the extent such instruments have similar economic characteristics to the investments included within that policy.

Our 80% policy with respect to investments in credit and credit-related instruments is not fundamental and may be changed by the Board without prior approval of our shareholders. Shareholders will be provided with sixty (60) days notice in the manner prescribed by the SEC before making any change to this policy.

Investment Restrictions

The Fund’s stated fundamental policies, which may only be changed by the affirmative vote of a majority of the outstanding voting securities of the Fund (the shares), are listed below. “Majority of the outstanding voting securities of the Fund” means the vote, at an annual or special meeting of shareholders, duly called, (a) of 67% or more of the shares present at such meeting, if the holders of more than 50% of the outstanding shares are present or represented by proxy; or (b) of more than 50% of the outstanding shares, whichever is less. The Fund may not:

1.Borrow money, except to the extent permitted by the 1940 Act (which currently limits borrowing to no more than 33-1/3% of the value of the Fund’s total assets, including the value of the assets purchased with the proceeds of its indebtedness, if any). The Fund may borrow for investment purposes, for temporary liquidity, or to finance repurchases of its shares.

2.Issue senior securities, except to the extent permitted by Section 18 of the 1940 Act (which currently limits the issuance of a class of senior securities that is indebtedness to no more than 33-1/3% of the value of the Fund’s total assets or, if the class of senior security is stock, to no more than 50% of the value of the Fund’s total assets).

3.Underwrite securities of other issuers, except insofar as the Fund may be deemed an underwriter under the Securities Act of 1933, as amended (the “Securities Act”) in connection with the disposition of its portfolio securities. The Fund may invest in restricted securities (those that must be registered under the Securities Act before they may be offered or sold to the public) to the extent permitted by the 1940 Act.

4.Invest more than 25% of the market value of its assets in the securities of companies, entities or issuers engaged in any one industry. This limitation does not apply to investment in the securities of the U.S. Government, its agencies or instrumentalities. For purposes of this restriction, an investment in a CLO, CBO, collateralized debt obligation, or “CDO” or a swap or other derivative will be considered to be an investment in the industry (if any) of the underlying or reference security, instrument or asset.

5.Purchase or sell real estate or interests in real estate. This limitation is not applicable to investments in securities that are secured by or represent interests in real estate (e.g. mortgage loans evidenced by notes or other writings defined to be a type of security). Additionally, the preceding limitation on real estate or interests in real estate does not preclude the Fund from investing in mortgage-related securities or investing in companies engaged in the real estate business or that have a significant portion of their assets in real estate (including real estate investment trusts), nor from disposing of real estate that may be acquired pursuant to a foreclosure (or equivalent procedure) upon a security interest.

6.Purchase or sell commodities, commodity contracts, including commodity futures contracts, unless acquired as a result of ownership of securities or other investments, except that the Fund may invest in securities or other instruments backed by or linked to commodities, and invest in companies that are engaged in a commodities business or have a significant portion of their assets in commodities, and may invest in commodity pools and other entities that purchase and sell commodities and commodity contracts.

7.Make loans to others, except (a) through the purchase of debt securities in accordance with its investment objectives and policies, including notes secured by real estate, which may be considered loans; (b) to the extent the entry into a repurchase agreement is deemed to be a loan; and (c) by loaning portfolio securities. Additionally, the preceding limitation on loans does not preclude the Fund from modifying note terms.

The Fund will treat with respect to participation interests both the financial intermediary and the borrower as “issuers” for purposes of fundamental investment restriction.

The fundamental investment limitations set forth above restrict the ability of the Fund to engage in certain practices and purchase securities and other instruments other than as permitted by, or consistent with, applicable law, including the 1940 Act. Relevant limitations of the 1940 Act as they presently exist are described below. These limitations are based either on the 1940 Act itself, the rules or regulations thereunder or applicable orders of the SEC. In addition, interpretations and guidance provided by the SEC staff may be taken into account to determine if a certain practice or the purchase of securities or other instruments is permitted by the 1940 Act, the rules or regulations thereunder or applicable orders of the SEC. As a result, the foregoing fundamental investment policies may be interpreted differently over time as the statute, rules, regulations or orders (or, if applicable, interpretations) that relate to the meaning and effect of these policies change, and no vote of Shareholders, as applicable, will be required or sought.

Use of Leverage and Leverage Risks

The use of leverage, whether directly or indirectly through investments such as CLO equity or junior debt securities that inherently involve leverage, may magnify our risk of loss. CLO equity or junior debt securities are very highly leveraged (with CLO equity securities typically being leveraged ten times), and therefore the CLO securities in which we invest are subject to a higher degree of loss since the use of leverage magnifies losses.

We may incur leverage, directly or indirectly, through one or more special purpose vehicles (entities primarily engaged in investment activities in securities or other assets that are wholly owned by the Fund), indebtedness for borrowed money, as well as leverage in the form of Derivative Transactions, preferred shares, debt securities and other structures and instruments, in significant amounts and on terms that the Adviser and the Board deem appropriate, subject to applicable limitations under the 1940 Act. Such leverage may be used for the acquisition and financing of our investments, to pay fees and expenses and for other purposes. Such leverage may be secured and/or unsecured. Any such leverage does not include leverage embedded or inherent in the CLO structures in which we invest or in derivative instruments in which we may invest. Accordingly, there is a layering of leverage in our overall structure.

The more leverage we employ, the more likely a substantial change will occur in our NAV. Accordingly, any event that adversely affects the value of an investment would be magnified to the extent leverage is utilized. For instance, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Such a decline could also negatively affect our ability to make distributions and other payments to our security holders. Leverage is generally considered a speculative investment technique. Our ability to service any debt that we incur will depend largely on our financial performance and will be subject to prevailing economic conditions and competitive pressures. The cumulative effect of the use of leverage with respect to any investments in a market that moves adversely to such investments could result in a substantial loss that would be greater than if our investments were not leveraged.

As a registered closed-end management investment company, we are required to meet certain asset coverage requirements, as defined under the 1940 Act, with respect to any senior securities. With respect to senior securities representing indebtedness (i.e., borrowings or deemed borrowings, including any notes), other than temporary borrowings as defined under the 1940 Act, we are required under current law to have an asset coverage of at least 300%, as measured at the time of borrowing and calculated as the ratio of our total assets (less all liabilities and indebtedness not represented by senior securities) over the aggregate amount of our outstanding senior securities representing indebtedness. With respect to senior securities that are stock (i.e., our preferred shares), we are required under current law to have an asset coverage of at least 200%, as measured at the time of the issuance of any such preferred shares and calculated as the ratio of our total assets (less all liabilities and indebtedness not represented by senior securities) over the aggregate amount of our outstanding senior securities representing indebtedness plus the aggregate liquidation preference of any outstanding preferred shares. If legislation were passed that modifies this section of the 1940 Act and increases the amount of senior securities that we may incur, we may increase our leverage to the extent then permitted by the 1940 Act and the risks associated with an investment in us may increase.

If our asset coverage declines below 300% (or 200%, as applicable), we would not be able to incur additional debt or issue additional preferred shares, and could be required by law to sell a portion of our investments to repay some debt or redeem preferred shares when it is disadvantageous to do so, which could have a material adverse effect on our operations, and we may not be able to make certain distributions or pay dividends of an amount necessary to continue to be subject to tax as a RIC. The amount of leverage that we employ will depend on the Adviser’s and the Board’s assessment of market and other factors at the time of any proposed borrowing. We cannot assure you that we will be able to obtain credit at all or on terms acceptable to us.

In addition, any debt facility into which we may enter would likely impose financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our ability to be subject to tax as a RIC under Subchapter M of the Code.

The following table illustrates the effects of the Fund’s leverage due to senior securities on corresponding share total return, assuming investment portfolio total returns (consisting of income and changes in the value of investments held in the Fund’s portfolio) of -10%, -5%, 0%, 5% and 10%. These assumed investment portfolio returns are hypothetical figures and are not necessarily indicative of the investment portfolio returns expected to be experienced by the Fund. Your actual returns may be greater or less than those appearing below.

The following table assumes the Fund’s continued use of Preferred Shares represents 35.59% of the Fund’s Managed Assets, its Credit Facility represents 3.18% of the Fund’s Managed Assets as of September 30, 2025, and the Fund bears expenses relating to such Preferred Shares and borrowings at annualized average interest rates of 8.34% and 7.30%, respectively (based on dividend rates for such Preferred Shares and interest rates for such borrowings as of September 30, 2025). The table below also assumes the annual return that the Fund’s portfolio must experience (net of expenses not related to Preferred Shares and the Credit Facility) in order to cover the costs of such leverage would be 3.20%. These figures are estimates based on current market conditions and are used for illustration purposes only. Actual expenses associated with Preferred Shares and borrowings used by the Fund may vary frequently and may be significantly higher or lower than the rate used for the example below.


Assumed Return on Portfolio (Net of Expenses)	(10.00)%	(5.00)%	—%	5.00%	10.00%
Corresponding Share Total Return	(21.56)%	(13.40)%	(5.23)%	2.94%	11.10%

Principal Risk Factors

For a description of the principal risk factors associated with an investment in the Fund, please refer to Note 5. Risk Factors, to the Financial Statements.

Additional Information

We file with or submit to the SEC annual and semi-annual reports, proxy statements and other information meeting the informational requirements of the Exchange Act or pursuant to Rule 30b2-1 under the 1940 Act. The SEC maintains a website that contains reports, proxy and information statements and other information we file with the SEC at www.sec.gov. This information is also available free of charge on our website (www.carlylecreditincomefund.com) or by calling (866) 277-8243 (toll-free).

Forward Looking Statements

This report may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this report may constitute forward-looking

statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Fund’s filings with the SEC. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this report.

PERFORMANCE DATA

The graph presented below compares the cumulative shareholder return on our common shares with that of the S&P BDC Index. The Fund commenced operations on September 20, 2013; however prior to the close of business on July 14, 2023, the Fund was advised by a different investment adviser that is not affiliated with the Fund’s current adviser and the Fund’s performance for periods prior to July 14, 2023 are not shown in the graph below. Effective at the close of business on July 14, 2023, the Fund’s principal investment strategy was changed and the Fund seeks to achieve its investment objectives by investing primarily in equity and junior debt tranches of collateralized loan obligations, or “CLOs.” The Fund believes the S&P BDC Index is the most appropriate and relevant index for comparative purposes for this investment strategy.

The graph assumes an investment of $10,000 in the Fund since the change in investment adviser on July 14, 2023. Total return is calculated assuming reinvestment of all dividends and distributions. Returns shown do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the repurchase of fund shares.

Past performance is not indicative of future results or a guarantee of future returns. Future results may vary and may be higher or lower than the data shown.


	Annualized Total Return				Since Change in Strategy (July 14, 2023)
	3 Month	6 Month	9 Month	1 Year
Carlyle Credit Income Fund	(19.26)%	(9.16)%	(20.06)%	(15.09)%	2.40%
S&P BDC Index	(21.74)%	(12.25)%	(7.25)%	0.34%	9.16%

SUMMARY OF CERTAIN UNAUDITED PORTFOLIO CHARACTERISTICS

The information presented below is on a look-through basis to the collateralized loan obligation, or “CLO”, equity and related investments held by the Fund as of September 30, 2025, and reflects the aggregate underlying exposure of the Fund based on the portfolios of those investments. The data is estimated, unaudited, and derived from CLO trustee reports received by the Fund as of and for the year ended September 30, 2025 and from custody statements and/or other information received from CLO collateral managers, or third party sources.

Portfolio Investment Breakdown as of September 30, 2025

(Excludes cash equivalents and other assets)


Summary of Underlying Portfolio
Number of Unique Underlying Loan Obligors	1,479
Number of Underlying Loans	2,032
Aggregate Balance of Underlying Loans	$22.45 Billion
Average Individual Loan Obligor Exposure	0.07	%
Currency: USD Exposure	100.00	%
Aggregate Indirect Exposure to Senior Secured Loans	96.56	%
Weighted Average Junior OC Cushion	4.59	%
Weighted Average Market Price of Loan Collateral	97.53
Weighted Average Remaining CLO Reinvestment Period	3.25 years
CCIF’s Last 12 Month Default Rate including Distressed Exchanges of Underlying Loans	1.09	%
Loan Market Default Rate including Distressed Exchanges	3.49	%


Top 10 Underlying Obligors
Obligor	% Total
TransDigm	0.60	%
Calpine	0.54	%
Medline	0.50	%
Asurion	0.45	%
TIBCO Software	0.44	%
Quikrete Companies	0.44	%
Citadel Securities LP	0.43	%
Sedgwick Claims Management Service	0.43	%
Howden Group Holdings	0.40	%
Acrisure	0.40	%
Total	4.63	%


Top 10 Industries of Underlying Obligors
Industry	% Total
High Tech	12.34	%
Healthcare & Pharmaceuticals	11.69	%
Banking, Finance, Insurance & Real Estate	10.46	%
Services: Business	8.52	%
Hotels, Gaming & Leisure	5.12	%
Construction & Building	4.56	%
Beverage, Food & Tobacco	4.11	%
Capital Equipment	4.05	%
Aerospace & Defense	3.66	%
Chemicals, Plastics & Rubber	3.44	%
Total	67.95	%

Weighted Average Rating Distribution Weighted Average Maturity Distribution

Wtd Avg = B Wtd Avg = 4.6 yrs

WEIGHTED AVERAGE RATING DISTRIBUTION.jpg

WEIGHTED AVERAGE MATURITY DISTRIBUTION.jpg

Weighted Average Price Distribution Weighted Average Spread Distribution

Wtd Avg = 97.53 Wtd Avg = 3.12% WEIGHTED AVERAGE PRICE DISTRIBUTION.jpg

WEIGHTED AVERAGE STATED SPREAD DISTRIBUTION.jpg

FEES AND EXPENSES

The following table is intended to assist in understanding the costs and expenses that an investor in our common shares will bear, directly or indirectly, based on the assumptions set forth below. The expenses shown in the table under “Annual Expenses” are estimated amounts based on historical fees and expenses, as appropriate. We caution that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this table contains a reference to our fees or expenses, we will pay such fees and expenses out of our net assets and, consequently, shareholders will indirectly bear such fees or expenses as investors in the Fund.


SHAREHOLDER TRANSACTION FEES
Sales load	—	%	(1)
Offering expenses borne by the Fund	—	%	(2)
Dividend reinvestment plan expenses	—	%	(3)
Total shareholder transaction fees	—	%	(4)


ESTIMATED ANNUAL FUND EXPENSES (as a percentage of net assets attributable to common shares)
Management Fee	2.63	%	(5)
Incentive Fee payable under Investment Advisory Agreement (17.5%)	1.65	%	(6)
Interest payments and fees on borrowed funds	6.05	%	(7)
Other Expenses	1.75	%	(8)
Total annual fund expenses	12.08	%

1.In the event that the Fund sells its securities publicly through underwriters or agents the related prospectus supplement will disclose the applicable sales load.

2.In the event that the Fund sells its securities publicly through underwriters or agents the related prospectus supplement will disclose the estimated amount of total offering expenses (which may include offering expenses borne by third parties on the Fund’s behalf), the offering price and the offering expenses borne by the Fund as a percentage of the offering price.

3.The expenses of administering the dividend reinvestment plan (the “DRP”) are included in “Other Expenses.” Investors will pay brokerage charges if they direct their broker or the DRP Plan agent to sell their Common Shares that they acquired pursuant to the DRP. See “Dividend Reinvestment Plan.”

4.The related prospectus supplement will disclose the offering price and the total stockholder transaction expenses as a percentage of the offering price.

5.The Management Fee is calculated and payable monthly in arrears at the annual rate of 1.75% of the month-end value of the Fund’s managed Assets. “Managed Assets” means the total assets of the Fund (including any assets attributable to any preferred shares or to indebtedness) minus the Fund’s liabilities other than liabilities relating to indebtedness.

6.The Fund shall pay CGCIM an Incentive Fee calculated and payable quarterly in arrears based upon the Fund’s “pre-incentive fee net investment income” for the immediately preceding quarter, and is subject to a hurdle rate, expressed as a rate of return on the Fund’s net assets, equal to 2.00% per quarter (or an annualized hurdle rate of 8.00%), subject to a “catch-up” feature. For this purpose, “pre-incentive fee net investment income” means interest income, dividend income, income generated from original issue discounts, payment-in-kind income, and any other income earned or accrued during the calendar quarter, minus the Fund’s operating expenses (which, for this purpose shall not include any distribution and/or shareholder servicing fees, litigation, any extraordinary expenses or Incentive Fee) for the quarter. For purposes of computing the Fund’s pre-incentive fee net investment income, the calculation methodology will look through total return swaps as if the Fund owned the referenced assets directly. As a result, the Fund’s pre-incentive fee net investment income includes net interest, if any, associated with a derivative or swap, which is the difference between (a) the interest income and transaction fees related to the reference assets and (b) all interest and other expenses paid by the Fund to the derivative or swap counterparty. “Net assets” means the total assets of the Fund minus the Fund’s liabilities. For purposes of the Incentive Fee, net assets are calculated for the relevant quarter as the weighted average of the net asset value of the Fund as of the first business day of each month therein. The weighted average net asset value shall be calculated for each month by multiplying the net asset value as of the beginning of the first business day of the month times the number of days in that month, divided by the number of days in the applicable calendar quarter.

The calculation of the Incentive Fee for each calendar quarter is as follows:

•No Incentive Fee is payable to CGCIM if the Fund’s pre-incentive fee net investment income, expressed as a percentage of the Fund’s net assets in respect of the relevant calendar quarter, does not exceed the quarterly hurdle rate of 2.00%;

•100% of the portion of the Fund’s pre-incentive fee net investment income that exceeds the hurdle rate but is less than or equal to 2.4242% (the “catch-up”) is payable to CGCIM if the Fund’s pre-incentive fee net investment income, expressed as a percentage of the Fund’s net assets in respect of the relevant calendar quarter, exceeds the hurdle rate but is less than or equal to 2.4242% (9.6968% annualized). The “catch-up” provision is intended to provide CGCIM with an incentive fee of 17.5% on all of the Fund’s pre-incentive fee net investment income when the Fund’s pre-incentive fee net investment income reaches 2.4242% of net assets; and

•17.5% of the portion of the Fund’s pre-incentive fee net investment income that exceeds the “catch-up” is payable to CGCIM if the Fund’s pre-incentive fee net investment income, expressed as a percentage of the Fund’s net assets in respect of the relevant calendar quarter, exceeds 2.4242% (9.6968% annualized). As a result, once the hurdle rate is reached and the catch-up is achieved, 17.5% of all the Fund’s pre-incentive fee net investment income thereafter is allocated to CGCIM.

7.The Fund may issue preferred shares or debt securities. The above figure assumes an aggregate of $3.5 million of the Fund’s Series B Convertible Preferred Shares with an interest rate of 7.125% per annum, $20.0 million of the Fund’s Series C Convertible Preferred Shares with an interest rate of 7.50% per annum, $30.0 million of the Fund’s Series D Term Preferred Shares with an interest rate of 7.375%, and $17.5 million of the Fund’s Series E Convertible Preferred Shares with an interest rate of 7.25%. In the event that the Fund were to issue additional preferred shares or debt securities, the Fund’s borrowing costs, and correspondingly its total annual expenses, including, in the case of such preferred shares, the base management fee as a percentage of the Fund’s net assets attributable to common shares, would increase.

8.“Other expenses” includes the Fund’s overhead expenses, including payments under the Administration Agreement based on the Fund’s allocable portion of overhead and other expenses incurred by Administrator, and payment of fees in connection with outsourced administrative functions, and are based on estimated amounts for the current fiscal year. “Other expenses” also includes the ongoing administrative expenses to the independent accountants and legal counsel of the Fund, compensation of independent directors, and costs and expenses relating to rating agencies.

The following examples illustrate the hypothetical expenses that would be paid on a $1,000 investment assuming annual expenses attributable to common shares remain unchanged and common shares earn a 5% annual return:


Example	1 Year	3 Years	5 Years	10 Years
Expenses on a $1,000 investment, assuming a 5% annual return	$124	$345	$534	$898

The example and the expenses in the tables above should not be considered a representation of the Fund’s future expenses, and actual expenses may be greater or less than those shown. While the example assumes a 5.0% annual return, as required by the SEC, the Fund’s performance will vary and may result in a return greater or less than 5.0%.

CARLYLE CREDIT INCOME FUND

STATEMENT OF ASSETS AND LIABILITIES

As of September 30, 2025

(expressed in U.S. dollars)


	September 30, 2025
ASSETS
Investments, at fair value (cost $206,263,382)	$	192,203,718
Cash and cash equivalents	2,465,620
Interest receivable	6,192,755
Deferred financing costs	682,483
Receivable for investments sold	10,948,046
Prepaid expenses	282,662

Total assets	$	212,775,284

LIABILITIES

Preferred Shares (net of unamortized deferred issuance costs of $1,872,238) (Note 7)	$	73,644,762
Secured credit facility	6,750,000

Incentive fee payable	670,743
Management fee payable	305,632
Professional fees payable	739,283
Interest payable	366,228
Administration and custodian fees payable	162,714
Other payables and accrued expenses	222,300

Total liabilities	$	82,861,662

COMMITMENTS AND CONTINGENCIES (Note 8)

Net Assets	$	129,913,622

COMPOSITION OF NET ASSETS

Paid-in capital	$	151,629,695
Total distributable earnings (losses)	(21,716,073)
Total Net Assets	$	129,913,622
Common shares outstanding (no par value)	21,198,622
Net asset value per share of common stock	$	6.13

See accompanying Notes to Financial Statements.

CARLYLE CREDIT INCOME FUND

SCHEDULE OF INVESTMENTS

As of September 30, 2025

(expressed in U.S. dollars)


Issuer (1)(7)	Investment Description	Acquisition Date (2)	Principal Amount		Cost		Fair Value (3)		% of Net Assets
CLO - Equity(4)(5)
522 Funding CLO 2021-7, Ltd.	Subordinated Notes (effective yield 0.00%, 4/23/2034)8	7/27/2023	$	4,505,000	$	481,463	$	268,926	0.21	%
AGL CLO 17, Ltd.	Subordinated Notes (effective yield 16.29%, 1/21/2035)	5/6/2024	2,750,000		1,912,404		1,674,561		1.29	%
Aimco CLO 10, Ltd.	Subordinated Notes (effective yield 13.00%, 7/22/2032)	11/27/2023	11,071,800		6,030,589		5,787,370		4.45	%
Aimco CLO 14, Ltd.	Subordinated Notes (effective yield 11.79%, 4/20/2034)	7/17/2023	6,200,000		4,270,383		4,549,343		3.50	%
Allegro XVII, Ltd.	Subordinated Notes (effective yield 11.26%, 7/25/2038)6	5/07/2025	1,875,000		1,494,271		1,460,690		1.12	%
Apidos CLO XXV, Ltd.	Subordinated Notes (effective yield 15.90%, 1/20/2037)	7/1/2025	6,000,000		2,242,584		2,028,065		1.56	%
Apidos CLO XXXIII, Ltd.	Subordinated Notes (effective yield 12.57%, 10/24/2034)6	7/25/2024	22,780,000		12,355,829		12,049,918		9.28	%
Apidos CLO XXXIX, Ltd.	Subordinated Notes (effective yield 12.32%, 4/21/2035)	5/2/2024	5,710,000		3,719,833		3,376,793		2.60	%
Ares LIX CLO, Ltd.	Subordinated Notes (effective yield 19.36%, 4/25/2034)	12/7/2023	8,000,000		4,274,067		3,941,352		3.03	%
Ares LV CLO, Ltd.	Subordinated Notes (effective yield 13.94%, 10/15/2037)	8/19/2025	7,500,000		5,409,375		5,199,049		4.00	%
Ares LVI CLO, Ltd.	Subordinated Notes (effective yield 16.72%, 1/25/2038)	8/24/2023	4,751,000		2,819,779		2,956,606		2.28	%
Ares LX CLO, Ltd.	Subordinated Notes (effective yield 19.39%, 7/18/2034)	11/29/2023	1,600,000		769,476		743,983		0.57	%
Ares LXXIV CLO, Ltd.	Subordinated Notes (effective yield 11.91%, 10/15/2037)	7/23/2025	4,000,000		3,325,000		3,284,658		2.53	%
Audax CLO 12, Ltd.	Subordinated Notes (effective yield 15.51%, 4/22/2037)	3/03/2025	1,330,000		1,230,250		1,199,310		0.92	%
Ballyrock CLO 15, Ltd.	Subordinated Notes (effective yield 13.79%, 1/15/2038)	8/16/2023	5,450,000		3,413,252		3,079,644		2.37	%
Ballyrock CLO 16, Ltd.	Subordinated Notes (effective yield 17.28%, 7/20/2034)	8/20/2024	5,867,000		3,356,512		3,204,649		2.47	%
Ballyrock CLO 18, Ltd.	Subordinated Notes (effective yield 13.97%, 4/15/2038)	8/16/2023	3,260,000		1,923,546		1,718,807		1.32	%
Barings CLO, Ltd. 2019-III	Subordinated Notes (effective yield 18.54%, 1/20/2036)6	12/13/2023	7,695,466		3,534,196		3,350,965		2.58	%
Barings CLO, Ltd. 2021-I	Subordinated Notes (effective yield 17.63%, 4/25/2034)	7/17/2023	3,400,000		1,872,625		1,437,359		1.11	%
Barings CLO, Ltd. 2025-I	Subordinated Notes (effective yield 13.27%, 4/20/2038)	2/14/2025	6,000,000		5,184,000		4,960,581		3.82	%
Benefit Street Partners CLO XXIII, Ltd.	Subordinated Notes (effective yield 21.63%, 4/25/2034)	8/02/2023	10,000,000		6,250,685		6,745,736		5.19	%
Benefit Street Partners CLO XXXVIII, Ltd.	Subordinated Notes (effective yield 10.52%, 1/25/2038)	12/17/2024	5,000,000		4,733,139		4,361,582		3.36	%
Birch Grove CLO 3, Ltd.	Subordinated Notes (effective yield 15.14%, 1/19/2038)	9/4/2024	8,602,500		6,942,420		6,668,832		5.13	%
CIFC Funding 2020-II, Ltd.	Subordinated Notes (effective yield 14.02%, 10/20/2034)	2/11/2025	5,000,000		3,239,283		2,753,609		2.12	%
CIFC Funding 2020-III, Ltd.	Subordinated Notes (effective yield 12.92%, 10/20/2034)	9/20/2023	8,750,000		6,022,485		5,040,118		3.88	%
Davis Park CLO, Ltd.	Subordinated Notes (effective yield 11.20%, 4/20/2035)	2/11/2025	5,822,940		4,073,946		3,931,247		3.03	%
Elmwood CLO 17, Ltd.	Subordinated Notes (effective yield 13.50%, 7/17/2037)	8/13/2025	17,500,000		11,555,250		11,302,944		8.70	%
Elmwood CLO VII, Ltd.	Subordinated Notes (effective yield 12.33%, 1/17/2034)	7/17/2023	3,400,000		1,598,696		1,485,176		1.14	%
Empower CLO 2022-1, Ltd.	Subordinated Notes (effective yield 14.11%, 10/20/2037)	9/27/2024	9,500,000		7,464,604		6,818,464		5.25	%
Galaxy XXII CLO, Ltd.	Subordinated Notes (effective yield 16.66%, 4/16/2034)	12/15/2023	3,560,000		1,880,314		1,271,699		0.98	%
KKR CLO 25, Ltd.	Subordinated Notes (effective yield 16.91%, 7/15/2034)	12/11/2023	2,500,000		1,572,921		1,086,934		0.84	%
MidOcean Credit CLO XI, Ltd.	Subordinated Notes (effective yield 17.79%, 1/18/2036)	1/12/2024	6,250,000		3,795,032		3,720,069		2.86	%

CARLYLE CREDIT INCOME FUND

SCHEDULE OF INVESTMENTS

As of September 30, 2025

(expressed in U.S. dollars)


Issuer (1)(7)	Investment Description	Acquisition Date (2)	Principal Amount		Cost		Fair Value (3)		% of Net Assets
MidOcean Credit CLO XIV, Ltd.	Subordinated Notes (effective yield 11.06%, 4/15/2037)6	2/15/2024	$	6,750,000	$	4,510,173	$	3,977,980	3.06	%
Neuberger Berman Loan Advisers CLO 38, Ltd.	Subordinated Notes (effective yield 20.36%, 10/20/2035)	8/1/2023	9,500,000		5,160,348		4,998,040		3.85	%
Neuberger Berman Loan Advisers CLO 41, Ltd.	Subordinated Notes (effective yield 13.18%, 4/15/2034)	11/1/2023	4,500,000		2,480,389		2,183,786		1.68	%
Niagara Park CLO, Ltd.	Subordinated Notes (effective yield 18.02%, 1/17/2038)	12/1/2023	7,850,000		4,231,278		4,528,517		3.49	%
Niagara Park CLO, Ltd.	Subordinated Notes (effective yield 11.20%, 1/17/2038)	11/6/2024	425,000		227,195		404,157		0.31	%
Oaktree CLO 2019-3, Ltd.	Subordinated Notes (effective yield 15.14%, 1/20/2038)	6/12/2025	3,500,000		2,082,225		2,001,692		1.54	%
OCP CLO 2015-9, Ltd.	Subordinated Notes (effective yield 14.92%, 1/15/2037)	12/6/2023	21,847,700		8,075,051		8,838,605		6.80	%
OCP CLO 2017-13, Ltd.	Subordinated Notes (effective yield 11.54%, 11/26/2037)	5/13/2025	17,897,237		5,921,279		5,681,395		4.37	%
Octagon 55, Ltd.	Subordinated Notes (effective yield 14.51%, 7/20/2034)	7/19/2023	9,691,000		4,382,510		3,692,847		2.84	%
OHA Credit Partners XIII, Ltd.	Subordinated Notes (effective yield 15.82%, 10/21/2034)	7/17/2023	2,950,000		1,702,274		1,903,316		1.47	%
RAD CLO 12, Ltd.	Subordinated Notes (effective yield 12.44%, 10/30/2034)	11/5/2024	7,396,000		4,382,554		3,547,732		2.73	%
RR 12, Ltd.	Subordinated Notes (effective yield 16.00%, 1/15/2036)	7/31/2024	8,542,000		2,520,434		1,851,092		1.42	%
RR 6, Ltd.	Subordinated Notes (effective yield 0.00%, 4/15/2036)8	4/25/2024	2,206,250		1,017,197		264,070		0.20	%
Signal Peak CLO 10, Ltd.	Subordinated Notes (effective yield 15.50%, 1/24/2038)	3/28/2024	3,775,995		2,243,009		2,166,380		1.67	%
Signal Peak CLO 9, Ltd.	Subordinated Notes (effective yield 16.92%, 1/21/2038)	6/4/2025	10,664,718		5,824,422		4,978,858		3.83	%
Silver Point CLO 4, Ltd.	Subordinated Notes (effective yield 13.71%, 4/15/2037)	2/28/2025	7,140,000		4,534,702		4,272,824		3.29	%
Voya CLO 2020-2, Ltd.	Subordinated Notes (effective yield 13.89%, 7/19/2034)	8/02/2023	13,597,500		9,975,981		9,349,151		7.20	%
Voya CLO 2020-3, Ltd.	Subordinated Notes (effective yield 12.56%, 1/20/2038)	8/3/2023	5,798,000		3,849,777		3,501,813		2.70	%
Total CLO Equity					$	201,869,007	$	189,601,294	145.94	%
CLO - Debt(4)
Apidos CLO XXXIII, Ltd.	12.87% (3M Term SOFR + 8.55%, 4/24/2038)	4/23/2025	$	250,000	$	230,269	$	242,794	0.19	%
Total CLO Debt					$	230,269	$	242,794	0.19	%
CLO - Subordinated Fee Note (4)(5)
Davis Park CLO, Ltd.	Subordinated Fee Notes (effective yield 41.27%, 4/20/2035)	2/11/2025	$	5,822,940	$	35,876	$	46,650	0.04	%
Davis Park CLO, Ltd.	Subordinated Fee Notes (effective yield 39.72%, 4/20/2035)	2/11/2025	5,822,940		86,268		111,417		0.08	%
Neuberger Berman Loan Advisers CLO 38, Ltd.	Subordinated Fee Notes (effective yield 23.61%, 10/20/2035)	8/1/2023	69,788		38,083		26,563		0.02	%
Total CLO Subordinated Fee Notes					$	160,227	$	184,630	0.14	%
Real Estate(9)
Moores Crossing - Travis County, TX		7/14/2023	$	4,000,000	$	4,003,879	$	2,175,000	1.68	%

Total Investments					$	206,263,382	$	192,203,718	147.95	%

Cash Equivalents
City National Bank MMDA	Money Market Deposit Account		$	2,008,834	$	2,008,834	$	2,008,834	1.55	%
U.S. Bank MMDA	Money Market Deposit Account		456,786		456,786		456,786		0.35	%
Total Cash Equivalents					$	2,465,620	$	2,465,620	1.90	%

Total Investments and Cash Equivalents					$	208,729,002	$	194,669,338	149.85	%

CARLYLE CREDIT INCOME FUND

SCHEDULE OF INVESTMENTS

As of September 30, 2025

(expressed in U.S. dollars)

(1) The Fund is not affiliated with, nor does it "control" (as such term is defined in the Investment Company Act of 1940 (the "1940 Act")), any of the issuers listed. In general, under the 1940 Act, the Fund would be presumed to "control" an issuer if it owned 25% or more of its voting securities.

(2) Acquisition date represents the initial date of purchase or the date the investment was contributed to the Fund at the time of the Fund's formation.

(3) Fair value is determined by the Adviser in accordance with the written valuation policies and procedures, subject to oversight by the Fund's Board of Trustees, in accordance with Rule 2a-5 under the 1940 Act.

(4) Securities exempt from registration under the Securities Act of 1933, and are deemed to be "restricted securities." As of September 30, 2025, the aggregate fair value of these securities is $190,028,718, or 146.27% of the Fund's net assets.

(5) CLO subordinated notes and subordinated fee notes are considered CLO equity positions. CLO equity positions are entitled to recurring distributions which are generally equal to the remaining cash flow of payments made by underlying assets less contractual payments to debt holders and fund expenses. The effective yield is estimated based upon the current projection of the amount and timing of these recurring distributions in addition to the estimated amount of terminal principal payment. It is the Fund's policy to calculate the effective yield for each CLO equity position held within the Fund's portfolio at the initiation of each investment and to update it each subsequent quarter thereafter. The effective yield and investment cost may ultimately not be realized. As of September 30, 2025, the Fund's weighted average effective yield on its aggregate CLO equity positions, based on current amortized cost, was 14.44%. When excluding called CLOs, the Fund’s weighted average effective yield on its CLO equity positions was 14.55%.

(6) Fair value includes the Fund’s interests in fee rebates on the CLO subordinated notes.

(7) The fair value of the investment was determined using significant unobservable inputs. See “Note 3. Fair Value Measurements.”

(8) As of September 30, 2025, the investment has been called. Expected value of residual distributions, once received, is anticipated to be recognized as return of capital, pending any remaining amortized cost, and/or realized gain for any amounts received in excess of such amortized cost.

(9) The Fund inherited a non-income producing defaulted real estate loan from VCIF that was not included in the legacy portfolio sale. Pursuant to a deed-in-lieu of foreclosure on August 10, 2023, the Fund has ownership of the real estate.

See accompanying Notes to Financial Statements.

CARLYLE CREDIT INCOME FUND

STATEMENT OF OPERATIONS

For the Year Ended September 30, 2025

(expressed in U.S. dollars)


	Year Ended September 30, 2025
Investment Income
Interest income	$	33,179,036

Total investment income	33,179,036

Expenses
Interest expense	8,597,149
Management fees	3,623,309
Incentive fees	3,225,894
Professional fees	1,076,988
Administration and custodian fees	666,685
Insurance expense	238,533
Printing expense	140,869
Transfer agent fees	134,999
Trustees' fees and expenses	125,000
Other expenses	140,745



Total expenses	17,970,171


Net Investment Income	15,208,865

Net Realized and Unrealized Gain (Loss)
Net realized gain (loss) on investments and foreign currency transactions	(17,706,825)

Net change in unrealized appreciation (depreciation) on investments, foreign currency, and cash equivalents	(3,504,909)
Net Realized and Unrealized Gain (Loss)	(21,211,734)

Net Decrease in Net Assets Attributable to Common Shares from Operations	$	(6,002,869)

See accompanying Notes to the Financial Statements.

CARLYLE CREDIT INCOME FUND

STATEMENTS OF CHANGES IN NET ASSETS

For the Years Ended September 30, 2025 and September 30, 2024

(expressed in U.S. dollars)



	Year Ended September 30, 2025		Year Ended September 30, 2024
Net increase (decrease) in net assets from operations:
Net investment income	$	15,208,865	$	15,045,543
Net realized gain (loss) on investments and foreign currency transactions	(17,706,825)		99,225
Net change in unrealized appreciation (depreciation) on investments, foreign currency and cash equivalents	(3,504,909)		(9,578,026)
Net increase (decrease) in net assets resulting from operations	(6,002,869)		5,566,742

Distributions to shareholders from:
Net investment income	(10,363,754)		(427,365)
Return of capital	(13,459,803)		(15,218,076)
Total distributions to shareholders	(23,823,557)		(15,645,441)

Capital share transactions
Net increase (decrease) in net assets resulting from beneficial interest:
Issuance of common shares	40,303,512		28,063,654
Reinvestment of dividends	1,823,533		877,308
Net increase in net assets from capital share transactions	42,127,045		28,940,962


Total increase (decrease) in net assets	12,300,619		18,862,263
Net assets at the beginning of the period	117,613,003		98,750,740
Net assets at the end of the period	$	129,913,622	$	117,613,003

See accompanying Notes to Financial Statements.

CARLYLE CREDIT INCOME FUND

STATEMENT OF CASH FLOWS

For the Year Ended September 30, 2025

(expressed in U.S. dollars)


	Year Ended September 30, 2025
Cash flows from operating activities
Net decrease in net assets resulting from operations	$	(6,002,869)
Adjustments to reconcile net decrease in net assets from operations to net cash provided by operating activities:
Purchases of investments, net of change in payable for investments purchased	(106,130,703)
Proceeds from disposition of investments and reductions to investment cost value (1)	55,221,617
Net amortization on investments	(499)
Amortization of deferred issuance costs on preferred shares and credit facility	2,399,937
Net realized loss on investments	17,706,825
Net change in unrealized depreciation on investments	3,504,909
Changes in assets:
Increase in interest receivable	(154,212)

Decrease in prepaid expenses and other assets	294,081
Changes in liabilities:

Decrease in incentive fee payable	(230,211)
Increase in management fee payable	44,727
Increase in interest payable on preferred shares	288,728
Increase in professional fees payable	103,398
Increase in administration and custodian fees payable	116,605
Decrease in other payables and accrued expenses	(166,513)
Net cash used in operating activities	(33,004,180)

Cash flows from financing activities
Borrowings on credit facility	26,000,000
Repayments on credit facility	(19,250,000)
Deferred issuance costs paid for the credit facility	(737,620)
Proceeds from the issuance of preferred shares	20,000,000
Deferred issuance costs for the issuance of preferred shares	(1,571,470)
Proceeds from common shares issued, net of commissions and fees	32,303,512
Dividends paid to shareholders, net of reinvestments	(22,000,024)




Net cash provided by financing activities	34,744,398

Net increase in cash and cash equivalents	1,740,218
Cash and cash equivalents, beginning of period	725,402
Cash and cash equivalents, end of period	$	2,465,620


Supplemental information:

Cash paid for interest on preferred shares	$	5,867,872
Non-cash activities:
Reinvestment of dividends	$	1,823,533
Conversion of preferred shares to common shares (net of deferred issuance costs)	$	7,785,030

(1) Proceeds from the disposition of investments and reductions to investment cost value includes $14,422,841 of return of capital on CLO equity investments from recurring cash flows and distributions from called deals and refinancings during the year ended September 30, 2025.

See accompanying Notes to Financial Statements.

CARLYLE CREDIT INCOME FUND

FINANCIAL HIGHLIGHTS


	Year Ended September 30, 2025			Year Ended September 30,
				2024			2023(6)				2022			2021
Per Share Operating Data
Net asset value, beginning of period	$	7.64		$	8.42		$	10.39			$	11.69		$	12.05
Income (loss) from investment operations:
Net investment income (1)	0.81			1.19			0.05				0.50			0.42
Net realized and unrealized gain (loss) (2)	(1.13)			(0.74)			(1.20)				(0.80)			0.33
Total from investment operations	(0.32)			0.45			(1.15)				(0.30)			0.75
Dividends to shareholders from:
Net investment income (3)	(0.55)			(0.03)			(0.43)				(0.73)			(0.89)
Net realized gains (3)	—			—			—				(0.18)			(0.22)
Return of capital (3)	(0.71)			(1.20)			(0.40)				(0.09)			—
Total dividends	(1.26)			(1.23)			(0.82)			—	(1.00)			(1.11)
Effect of shares issued	$	0.07		$	—		$	—			$	—		$	—
Net asset value, end of period	$	6.13		$	7.64		$	8.42			$	10.39		$	11.69
Per share market value at beginning of period	$	8.23		$	8.18		$	8.92			$	10.49		$	9.93
Per share market value at end of period	$	5.82		$	8.23		$	8.18			$	8.92		$	10.49

Total Return based on Net Asset Value (4)	(3.74)		%	6.07		%	(11.75)		%		(2.77)		%	6.52		%
Total Return based on Market Value (4)	(15.09)		%	17.21		%	0.39		%		(5.95)		%	17.59		%
Ratios/Supplemental Data
Net assets, end of period (in thousands)	$	129,914		$	117,613		$	98,751			$	107,829		$	121,324
Ratio of gross expenses to average net assets (5)	13.85		%	12.92		%	7.42		%		3.27		%	3.05		%
Ratio of net expenses to average net assets (5)	13.85		%	12.92		%	6.72		%		3.09		%	2.88		%
Ratio of net expenses before incentive fees to average net assets (5)	11.36		%	9.72		%	N/A				N/A			N/A
Ratio of net investment income to average net assets (5)	11.72		%	15.10		%	0.56		%		4.53		%	3.56		%
Portfolio turnover rate	28.91		%	17.69		%	100.91		%		28.39		%	14.73		%
Asset coverage of preferred shares and credit facility	258		%	285		%	N/A				N/A			N/A
Loan Outstanding, End of Year/Period (in thousands) (7)	$	6,750		N/A			N/A				$	7,455		$	1,923
Asset Coverage Ratio for Loan Outstanding (7)	3143		%	N/A			N/A				1546		%	6409		%
Asset Coverage, per $1,000 Principal Amount of Loan Outstanding (7)	$	31,434		N/A			N/A				$	15,463		$	64,090
Weighted Average Loans Outstanding (in thousands) (7)	$	7,542		N/A			$	3,732			$	8,051		$	10,788
Weighted Average Interest Rate on Loans Outstanding (7)	7.45		%	N/A			7.94		%		4.50		%	3.75		%

(1) Per share amounts are calculated based on the average shares outstanding during the period.

(2) Net realized and unrealized gain (loss) includes adjustments to reconcile change in net asset value (“NAV”) per share. The amount may not agree with the change in the aggregate net realized and unrealized gain (loss) due to the timing of the issuance of the Fund’s common shares in relation to fluctuating market values for the portfolio.

(3) Management monitors available taxable earnings to determine if a tax return of capital may occur for the period. To the extent the Fund’s taxable earnings fall below the total amount of the Fund’s distributions for that fiscal year, a portion of those distributions may be deemed a tax return of capital to the Fund’s shareholders. The ultimate tax character of the Fund’s earnings cannot be determined until tax returns are prepared after the end of the fiscal year.

(4) Total returns are historical in nature and assume changes in share price, reinvestment of dividends and capital gains distributions, if any, and excludes the effect of sales charges. Had the Adviser not waived expenses, total returns would have been lower. Returns do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares.

(5) Annualized for periods less than one full year. For years ended September 2021, 2022, and 2023 the Fund waived certain expenses in connection with an expense limitation agreement. For the year ended September 30, 2025, there were no expenses waived. See Note 4. Related Party Transactions, for further information.

(6) Effective at the close of business on July 14, 2023, CGCIM replaced Oakline Advisors as the Fund’s new investment adviser and the Fund’s investment strategy was changed to invest primarily in debt and equity tranches issued by collateralized loan obligations. Prior to the close of business on July 14, 2023, the investment strategy was to invest primarily in mortgage notes secured by residential real estate.

CARLYLE CREDIT INCOME FUND

FINANCIAL HIGHLIGHTS (Continued)

(7) On July 11, 2025, the Fund entered into a revolving credit and security agreement (the “Credit Facility”). The weighted average loans outstanding and weighted average interest rate on loans outstanding are calculated from August 13, 2025 (initial date the Fund borrowed under the Credit Facility) through September 30, 2025. The obligations under the Credit Facility are secured by a first priority lien on substantially all of the Fund’s portfolio investments (see Note 6, Borrowings). A revolving line of credit agreement between the Fund and Nexbank was terminated on July 5, 2023.

Senior Securities

Class and Period Ended

Total Amount Outstanding Exclusive of Treasury

Securities (1)

Asset Coverage

Per Unit (2)

SEC Form N-CSR filed by Carlyle Credit Income Fund